(incorporated in Bermuda with limited liability)

(Stock code: 00858)

PROXY FORM

FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING

TO BE HELD ON FRIDAY, 28 AUGUST 2020 AT 11:00 A.M.

I/We (note a)

of

being the registered holder(s) of

(note b) shares of HK$0.01 each of

EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED (the ''Company'') hereby appoint the Chairman of the annual general meeting

(the ''Meeting'') of the Company or

of

to act as my/our proxy (note c) at the Meeting to be held at Forum Room II & III, Basement 2, Regal Hongkong Hotel, 88 Yee Wo Street, Causeway Bay, Hong Kong on Friday, 28 August 2020 at 11:00 a.m. (and at any adjournment thereof, as the case may be) and to vote on my/our behalf in respect of the ordinary resolutions set out in the notice (the ''Notice'') convening the Meeting as directed below, or, if no such indication is given, as my/our proxy thinks fit.

Please make a mark () in the appropriate boxes to indicate how you wish your vote(s) to be cast on a poll (note d).

ORDINARY RESOLUTIONS#

FOR

AGAINST

1. To receive and consider the audited financial statements and the reports of the directors and the auditor for the year ended 31 March 2020.

2.

(a)

To re-elect Mr. Cheng Yong as executive director.

(b)

To authorise the board of directors to fix the directors' remuneration.

3.

To re-appoint the Company's auditor and authorise the board of directors to fix its remuneration.

4. To grant a general mandate to the directors of the Company to allot, issue and otherwise deal with the Company's shares.

5.

To grant a general mandate to the directors of the Company to buy back the Company's shares.

6. To extend the general mandate granted to the directors of the Company to allot, issue and deal with the Company's shares by the addition thereto the nominal amount of the shares bought back by the Company.

  • Full text of the resolutions are set out in the Notice.

Shareholder's signature

(notes e, f, g and h)

Date:

2020

Notes:

  1. Full name(s) and address(es) are to be inserted in BLOCK CAPITALS. The names of all joint holders should be stated.
  2. Please insert the number of shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).
  3. A proxy need not be a member of the Company. If you wish to appoint some person other than the Chairman of the Meeting as your proxy, please delete the words ''the Chairman of the annual general meeting (the ''Meeting'') of the Company or'' and insert the name and address of the person appointed proxy in the space provided.
  4. If you wish to vote for any of the resolutions set out above, please tick (''✓'') the boxes marked ''For''. If you wish to vote against any of the resolutions, please tick (''✓'') the boxes marked ''Against''. If this form returned is duly signed but without specific direction on any of the proposed resolutions, the proxy will vote or abstain at his/her discretion in respect of all resolutions; or if in respect of a particular proposed resolution there is no specific direction, the proxy will, in relation to that particular proposed resolution, vote or abstain at his/her discretion. A proxy will also be entitled to vote at his/her discretion on any resolution properly put to the Meeting other than those set out in the Notice or any adjourned Meeting.
  5. In the case of joint holders, this form of proxy may be signed by any joint holder, but if more than one joint holder is present at the Meeting, whether in person or by proxy, that one of the joint holders whose name stands first on the register of members in respect of the relevant joint holding shall alone be entitled to vote in respect thereof.
  6. The form of proxy must be signed by a shareholder, or his/her attorney duly authorised in writing, or if the shareholder is a corporation, either under its common seal or under the hand of an officer or attorney so authorised.
  7. To be valid, this form of proxy together with any power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power or authority must be deposited at the Company's Hong Kong branch share registrar and transfer office, Tricor Tengis Limited at Level 54, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 48 hours before the time of the Meeting or any adjourned Meeting.
  8. Any alteration made to this form should be initialed by the person who signs the form.
  9. Due to COVID-19 and social distancing rules imposed by the Hong Kong Government, you are strongly encouraged to cast your votes by appointing the Chairman of the Meeting as your proxy to vote on the resolutions instead of appointing a proxy other than the Chairman of the Meeting or attending in person.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy's (or proxies') name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the Meeting of the Company (the ''Purposes''). We may transfer your and your proxy's (or proxies') name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorised by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy's (or proxies') name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to the Company/Tricor Tengis Limited at the above address.

  • For identification purpose only

C127090

Attachments

  • Original document
  • Permalink

Disclaimer

Extrawell Pharmaceutical Holdings Ltd. published this content on 27 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2020 09:05:13 UTC